Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura D Garrett

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of the American Veterinary Medical Association|February 16, 2011
Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007)Andrea B Flory, Kenneth M Rassnick, Hollis N Erb, et al.
Journal of the American Veterinary Medical Association|September 13, 2021
Spectrum of care: more than treatment optionsCarolyn R Brown, Laura D Garrett, William K Gilles, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2002
STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trialDavid M Vail, Ilene D Kurzman, Phyllis C Glawe, et al.
American Journal of Veterinary Research|August 21, 2003
Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogsCarolyn J Henry, Jeff W Tyler, Margaret C McEntee, et al.
Investigational New Drugs|May 26, 2010
Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogsPamela W Lucas, Joanna M Schmit, Quinn P Peterson, et al.
BMC Veterinary Research|June 12, 2015
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcomaHeather L Gardner, Cheryl A London, Roberta A Portela, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of the American Veterinary Medical Association|February 16, 2011
Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007)Andrea B Flory, Kenneth M Rassnick, Hollis N Erb, et al.
Journal of the American Veterinary Medical Association|September 13, 2021
Spectrum of care: more than treatment optionsCarolyn R Brown, Laura D Garrett, William K Gilles, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2002
STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trialDavid M Vail, Ilene D Kurzman, Phyllis C Glawe, et al.
American Journal of Veterinary Research|August 21, 2003
Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogsCarolyn J Henry, Jeff W Tyler, Margaret C McEntee, et al.
Investigational New Drugs|May 26, 2010
Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogsPamela W Lucas, Joanna M Schmit, Quinn P Peterson, et al.
BMC Veterinary Research|June 12, 2015
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcomaHeather L Gardner, Cheryl A London, Roberta A Portela, et al.
Pageof 3